Nuclear medicine vendor Trionix has always maintained a strongtechnological relationship with Sun Microsystems. Sun computerprocessing technology is built into the firm's high-end triple-and dual-detector SPECT cameras, the Triad and the Biad. The
Nuclear medicine vendor Trionix has always maintained a strongtechnological relationship with Sun Microsystems. Sun computerprocessing technology is built into the firm's high-end triple-and dual-detector SPECT cameras, the Triad and the Biad.
The partnership was strengthened this year as Trionix evolveda stronger nuclear networking focus, said President Chun Bin Lim.The Twinsburg, OH, vendor has developed two Sun-based workstations,which will be offered to customers independently of its SPECTcameras, he said.
"We maintain a close business relationship with Sun,"Lim told SCAN. "Now we have decided to make our joint computertechnology available as an independent product. This is part ofour evolutionary process."
Two Trionix workstations run on the Sun base:
Since many nuclear medicine clinics have cameras but not computers,image acquisition is essential to build efficient digital networks.Trionix's move into networking technology is part of an effortto offer more comprehensive services to its users, Lim said.
"After establishing our technical base, we needed to proveourselves as business managers," he said.
The next networking step for Trionix will be development ofa multimodality interface that helps users overlay the functionalnuclear display on anatomical images, he said.
"This year, we will address networking within the confinesof nuclear medicine clinics. Starting next year, we would liketo address the need to network (nuclear medicine) with other modalities,such as MRI and CT," he said.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.